Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.
Blueprint Genetics acquired by Quest Diagnostics
Andrew Alliance to be acquired by Waters Corporation
Insight Genetics to be acquired by OncoCyte
NeXtal Biotechnologies acquired by CalibreScientific